Prevention and control strategies of central sterile supply department under the normalization of the COVID-19 epidemic

doi:10.19871/j.cnki.xfcrbzz.2022.02.004

Abstract

Abstract: To complete the prevention and control strategies for the reprocessing of reusable medical devices in central sterile supply department (CSSD) under the normalization of the prevention and control of the coronavirus disease 2019 (COVID-19). Standardize and rationalize the process, prevent nosocomial infection, prevent and control the spread of infectious diseases, and ensure that the prevention and control of n COVID-19. The CSSD of Second Hospital of Nanjing (Jiangsu designated hospital for COVID-19) started from the requirements of epidemic prevention and control regulations, including overall prevention control strategies, personnel prevention and control strategies, reprocessing strategies for reused medical devices, and medical waste management. To carry out prevention and control management, formulate prevention and control procedures and systems, and strictly implement them. Through a series of prevention and control strategies, in the past two years of epidemic prevention and control, no nosocomial cross-infection occurred during the reprocessing of the reused equipment in CSSD. It provides a safety guarantee for the disinfection and supply of clinical reusable medical devices, and achieves good prevention and control results. This paper introduces the prevention and control strategy in detail for the reference of hospital CSSD.

Key words: Coronavirus disease 2019, Normalization of epidemic prevention and control central, Prevention and control strategies

Jiang Xuemei, Song Yan, Chen Yan, He li, Shao Wei. Prevention and control strategies of central sterile supply department under the normalization of the COVID-19 epidemic[J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 15-18.

References

[1] WORLD HEALTH ORGANIZATION.WHO Director–General's opening remarks at the media briefingon COVID-19-23 March 2020[EB/OL].[2020-03-23].http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c.shtml.
[2] 中华人民共和国国家卫生健康委员会疾病预防控制局.中华人民共和国国家卫生健康委员会公告:新型冠状病毒感染的肺炎纳入法定传染病管理[EB/OL]. [2020-01-20]. http://www.nhc.gov.cn/xcs/xxgzbd/202001/44a3b8245e8049d2837a4f27529cd386.shtm.
[3] 岑颖, 钱黎明, 张青, 等. 新型冠状病毒肺炎疑似或确诊患者复用医疗器械物品处置流程专家共识[J]. 中华护理杂志, 2020, 55(5):2.
[4] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].[2020-03-15].http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.html.
[5] 白建,郑东春,任清明,等.新型冠状病毒肺炎的流行病学特征与卫生防疫消毒方法[J].中华卫生杀虫药械,2020,26(1):87-91.
[6] 由娜,康博.新型冠状病毒肺炎疫情防控期间消毒供应中心的管理[J].护理研究,2020,34(5):769-771.
[7] 宋江南,陈贵秋,尹进,等.新型冠状病毒肺炎隔离场所实施的消毒处理[J].实用预防医学,2020,27(4):400-402.
[8] 邵蔚,张立,陈艳,等.医疗失效模式与效应分析在新型冠状病毒肺炎医院感染防控中的应用效果[J/CD].新发传染病电子杂志,2021,6(2):128-131.
[9] 中华护理学会消毒供应护理专业委员会.新冠肺炎疑似或确诊患者复用器械核物品处置流程指引[EB/OL]. [2020-04-02]. http://www.innomd.org/article/5e5329a7e214f3152bf57ffb.
[10] 中华人民共和国国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)[EB/OL].[2020-02-16].http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c.shtml.
[11] 蔡文峰,陈纯,王鸣.关注抗击新型冠状病毒肺炎中的过度消毒[J].热带医学杂志,2020,20(2):156-158.
[12] 北京市卫生健康委员会.关于做好医疗卫生机构生活垃圾和医疗废物分类管理工作的通知[EB/OL]. [2020-04-25].http://wjw.beijing.gov.cn/zwgk_20040/zxgk/202003/t20200326_1735877.html.
[13] 中华预防医学会新型冠状病毒肺炎防控专家组.新型冠状病毒肺炎流行病学特征的最新认识[J].中国病毒病杂志,2020,10(2):86-92.
[14] 詹昱新,李素云,刘义兰,等.综合医院应对新型冠状病毒肺炎疫情的护理应急管理[J].护理研究,2020,34(5):744-748.

[1]	Liu Wenhao, Yang Jinrong, Chen Yixin, Zhou Yun, Li Yinfeng, Yun Yongxing, Yang Gendong, Huang Hua. SARS-CoV-2 omicron variant strains infection: comparative analysis of clinical features in moderate group and mild/asymptomatic group and chest CT findings [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 6-10.
[2]	Liu Dong, Wang Shuaidi, Feng Mingnan, Huang Shunxing, Li Shuo, Du Xiaopeng, Liu Ya'ou, Ding Jinli. Clinical application of shelter CT in isolation area in the stage of regular COVID-19 prevention and control [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 11-14.
[3]	Infectious, Inflammatory Radiology Committee of Jiangsu Research Hospital Association, Quality Control Center of Jiangsu Diagnostic Radiology, Infectious Diseases Group of Radiology Branch of Jiangsu Medical Association. Consensus of experts on radiological examination, diagnosis, prevention and control rules for coronavirus disease 2019 in Jiangsu province (2^nd Edition 2022) [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(2): 79-88.
[4]	Liao Kangsheng, Lu Hongzhou. Current studies in 2019-nCoV Omicron variant: implications for scientific prevention and control strategies [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 1-5.
[5]	Yu Qi, Song Yan, Liu Sicong, Wang Mengmeng, Zhang Ailing. Investigation and analysis on knowledge and practice of nosocomial infection prevention and control of supporting nurses in non-infectious department [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 60-65.
[6]	Lu Hongxi, Liu Gang, Chen Xin. Analysis of virological characteristics of 2019-nCoV mutant strain concerned by WHO [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 88-91.
[7]	Wu Weigang, Yang Zhi, Ou Pengcheng, Zeng Furong, Lyu Xiaoqing, Wang Jialu, Guo Jianwei, Wu Shipin, Yang Guilin. The clinical value of diagnosis and treatment guidelines timely updated for prevention and control of COVID-19 [J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 100-103.
[8]	Zhan Xiangming, Lu Hongzhou. Research progress of the impact of COVID-19 on AIDS patients worldwide [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(4): 356-360.
[9]	Lu Chunrong, Fang Hongxia, Lu Puxuan, Ji Lecai. The global tuberculosis report 2021: key data analysis for China and the global world [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(4): 368-372.
[10]	Lu Qian, Gao Shitong, Liu Qu, Zhang Zhongming. Investigation, analysis and diagnosis of an imported COVID-19 case with ovale malaria in Guangdong Province [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 177-180.
[11]	Chen Qiuqi, Deng Guofang. WHO interpretation of guidelines for COVID-19 considerations for tuberculosis (TB) care [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(3): 265-269.
[12]	Yang Zhongping, Qin Yuanyuan, Zhou Yihong, Chen Yaokai. Clinical features and prognosis of COVID-19 among people living with HIV: a systematic literature analysis [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 113-118.
[13]	Shao Wei, Zhang Li, Chen Yan, Huang Ying, Wang Wenhui, Zhang Lijun, Sha Li. Application effect of HFMEA model in the prevention and control of nosocomial infection of coronavirus disease 2019 [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 129-132.
[14]	Li Shikang, Li Zhuo, Xu Ruiqing, Yan Xiaofeng, Li Jianhua, Lyu Liang, Song Yuyan, Sun Qiangzhong, Li Tongxin, Qian Lanlan, Zhang Ying. Multimodal deep learning for predicting COVID-19 patients at high-risk for serious illness [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 133-137.
[15]	Huang Bin, Gao Bo. The impact of COVID-19 on the nervous system [J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(2): 155-159.